Sequentia collaborated with Nextbiomics to obtain a novel immunization model against COVID-19

by rss feed | May 19, 2021 | News Feeds

Sequentia Biotech and NextBiomics announced the filing of a patent application for a bacterial vaccine against the COVID-19 syndrome. Read Original...

Presence of Anti-SARS-CoV-2 antibodies after 13 months of infection

by rss feed | May 19, 2021 | News Feeds

A new study has been published on the medRxiv* preprint server which focuses on validating the serological assays using a large cohort of healthcare workers. Read Original...

Glucosidase inhibitors hold promise as novel therapeutic agents against SARS-CoV-2

by rss feed | May 19, 2021 | News Feeds

In a new study posted to the bioRxiv* preprint server, researchers from the United States report that two iminosugar glucosidase inhibitors have the ability to suppress the replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in tissue...

How SARS-CoV-2 evolved from a bat-to a human-adapted virus

by rss feed | May 19, 2021 | News Feeds

New research published on the preprint server bioRxiv* performed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic simulations to understand the evolutionary transition from a bat-adapted SARS-CoV-2 to a human-adapted virus. Read Original...

Study identifies mechanism behind SARS-CoV-2 fusion of host cells

by rss feed | May 19, 2021 | News Feeds

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mediated by the fusion of the spike protein to nearby healthy cells. New research by German researchers sheds light on how this happens. Read Original...